Key Takeaways for Linde Stock as of August 2026
- Broad-Based Beat: Linde stock posted second-quarter revenue of $9,289 million, up 9.35% year over year and 3.04% ahead of Street estimates, while adjusted EPS of $4.50 beat by 0.31% and rose 10.02% YoY.
- Guide Raised, Not Rebuilt: Management lifted the full-year EPS range to $17.70-$17.90, raising the bottom end by $0.10 while holding the top unchanged, implying 8-9% growth for 2026.
- Margin Slippage: EBITDA margin came in at 38.45%, down 92bps versus Street and 99bps YoY, with the erosion concentrated in the Americas segment.
- Record Backlog, Homecare Drag: CEO Sanjiv Lamba flagged the U.S. homecare business as the primary margin culprit even as the sale of gas backlog hit a record $8.1B, and said Linde is evaluating whether that unit “earns its place in the portfolio.”
Record Backlog Masks a Homecare Problem Dragging on Linde Stock

Linde (LIN) delivered second-quarter revenue of $9,289 million, up 9.35% from a year earlier and 5.79% above the first quarter, beating Street estimates of $9,014.79 million by 3.04%. Adjusted EPS reached $4.50, a 10.02% jump from the $4.09 posted in the same period last year and a 0.31% beat versus consensus. Those headline numbers mask a margin story management itself called disappointing.
EBITDA margin fell to 38.45%, a decline of 99 basis points year over year and 92 basis points below what Wall Street had penciled in. EBIT margin slipped similarly, down 72 basis points versus Street to 29.54%. CEO Sanjiv Lamba pointed to the Americas segment as the main source, and specifically to the U.S. homecare business, known internally as Lincare. On the Q2 earnings call, he addressed the unit directly: “Even though we have been actively pruning this portfolio, it simply has not been enough to overcome the continued headwinds led by higher cost inflation and policy changes.” That admission carried weight, because Lincare’s drag was large enough that CFO Matt White estimated it running roughly 30% above the quarter’s hit when annualized.
Lamba went further than acknowledging the problem. He said Linde is now “evaluating the strategic fit of this U.S. homecare business within Linde, both in part and as a whole,” language that opens the door to a partial or full divestiture. That statement reframes the margin miss from a temporary blip into a portfolio decision management is actively weighing.
Set against that weakness, the backlog told a different story. Linde added $1 billion in new business during the quarter, pushing the sale of gas backlog to a record $8.1 billion after securing a new electronics win tied to advanced semiconductor fabs in the western United States. Lamba also expects the backlog to still carry an “8 handle” by year-end even after funding more than 20 project startups worth roughly $1.3 billion. That backlog strength is what let management raise full-year EPS guidance to $17.70-$17.90, lifting the low end by $0.10 while leaving the top of the range untouched, alongside third-quarter guidance of $4.45 to $4.55.
TIKR Values Linde Stock at $715, Pricing In Backlog-Driven Upside
TIKR’s mid-case model values Linde stock at $715 by December 2030, implying a 50% total return from the current price of $478, or 10% annualized over 4.4 years.

That return profile places Linde stock ahead of what investors typically expect from a mature industrial gas producer, where single-digit annualized returns are the norm rather than the exception.
The model’s reasoning tracks directly to what the quarter showed. Linde’s record $8.1 billion backlog, anchored by the new electronics win and more than 20 project startups worth $1.3 billion, supplies the revenue growth engine behind the target, while management’s raised full-year EPS guide of $17.70 to $17.90 confirms that earnings power is already showing up in the numbers. The homecare drag on margins is real, but it sits inside a business generating 9.35% revenue growth and a 10.02% EPS gain, giving the backlog room to offset a shrinking, lower-margin unit over time.
Should You Invest in Linde plc?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Linde plc stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Linde plc alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze LIN stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
